The role of β-blockers in chronic heart failure <br /> <br />

Journal Title: Αρχεία Ελληνικής Ιατρικής - Year 2003, Vol 20, Issue 1

Abstract

Until recently β-blockers were contraindicated for the treatment of chronic heart failure and their administration was avoided in heart failure patients. The use of β-blockers in heart failure is justified by the fact that increased activation of the adrenergic system in heart failure results in adverse biological signals to the cardiac myocytes. While the effects of β-blockers on exercise capacity and quality of life in heart failure patients are still controversial, clinical trials clearly show improvement in left ventricular function and reduction in its size, as well as fewer hospitalizations from aggravated heart failure. Four adequately powered β-blocker trials, US Carvedilol, CIBIS II, MERIT-HF and COPERNICUS, showed that treatment with β-blockers significantly reduced total and sudden death mortality in heart failure patients. Now, β-blockers are recommended for patients with mild to severe chronic heart failure (NYHA functional class II–IV) and with depressed left ventricular function. Uncertainties still persist about the use of β-blockers in patients with NYHA functional class I and in some specific patient groups with heart failure. Treatment with β-blockers should be started at a very low initial dosage and then titrated up to the maximal tolerated dosage. Today, despite impressive results in terms of morbidity and mortality, β-blocker use in heart failure patients is limited, with only a minority of them benefitting.

Authors and Affiliations

P. GEORGAKOPOULOS, M. KYRIAKIDIS

Keywords

Related Articles

Estimation of hemodialysis adequacy based<br /> on blood urea measurement at various time intervals <br /> during the dialysis session

OBJECTIVE The main hemodialysis (HD) adequacy index is Kt/V, depending, to a large extent, on the measurement of blood urea at the end of the dialysis session, which overestimates dialysis efficacy in proportion to the d...

ΒΙΒΛΙΟΠΑΡΟΥΣΙΑΣΗ

Βασικές, Ανώτερες και Εξειδικευμένες Νοσηλευτικές Δεξιότητες. Επιμέλεια: G.J. Baltopoulos

Biological and statistical interaction

The term “interaction” is used in statistics, epidemiology and pharmacology. In statistics, “interaction” is used to refer to departure from the underlying form of a statistical model (additive or multiplicative). In epi...

Oι λοιμώξεις στην παιδική ηλικία<br /> ως προδιαθεσικοί παράγοντες χρόνιων νοσημάτων

Η διάκριση μεταξύ λοιμωδών και χρόνιων νοσημάτων δεν μπορεί να γίνει πάντα με σαφήνεια και η σύγχυση των ορίων επιτάθηκε όταν συνειδητοποιήθηκε ότι ορισμένα οξέα λοιμώδη νοσήματα δεν μεταπίπτουν απλώς σε χρόνια, αλλά αυξ...

Download PDF file
  • EP ID EP112906
  • DOI -
  • Views 91
  • Downloads 0

How To Cite

P. GEORGAKOPOULOS, M. KYRIAKIDIS (2003). The role of β-blockers in chronic heart failure <br /> <br /> . Αρχεία Ελληνικής Ιατρικής, 20(1), 18-29. https://europub.co.uk/articles/-A-112906